Surgical Equipment & Consumables - Diversified Stocks Q4 Earnings: STERIS (NYSE:STE) Firing on All Cylinders
Michael J. Tokich, Medical Technology Industry Veteran, Nominated as Independent Director; Andrew A. Krakauer Appointed Chairman of the Board Effective Following 2026 Annual Meeting ...
1 S&P 500 Stock Worth Your Attention and 2 We Find Risky
1 Cash-Producing Stock on Our Buy List and 2 That Underwhelm
/Steris%20Plc%20logo%20and%20chart-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
STERIS has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know
/Dexcom%20Inc%20logo%20on%20sign-by%20Michael%20Vi%20via%20Shutterstock.jpg)
DexCom has underperformed the Nasdaq Composite over the past year, yet analysts remain highly optimistic about the stock’s future.
/Steris%20Plc%20site%20and%20phone-by%20T_Schneider%20via%20Shutterstock.jpg)
Despite STERIS' outperformance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.
The 5 Most Interesting Analyst Questions From STERIS’s Q4 Earnings Call